Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Sells $24,030,000.00 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Paul Vigano sold 3,000,000 shares of Aveanna Healthcare stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total value of $24,030,000.00. Following the completion of the sale, the insider directly owned 190,130 shares in the company, valued at approximately $1,522,941.30. The trade was a 94.04% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Aveanna Healthcare Stock Performance

AVAH stock opened at $9.10 on Friday. The firm has a fifty day moving average price of $7.36 and a 200 day moving average price of $7.57. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $3.73 and a fifty-two week high of $10.32. The company has a debt-to-equity ratio of 5.35, a quick ratio of 1.47 and a current ratio of 1.47. The firm has a market cap of $1.98 billion, a PE ratio of 7.71, a price-to-earnings-growth ratio of 0.94 and a beta of 1.89.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The company had revenue of $647.91 million for the quarter, compared to analysts’ expectations of $613.22 million. The business’s quarterly revenue was up 15.9% compared to the same quarter last year. Sell-side analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.65 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently weighed in on AVAH shares. Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $10.00 to $11.00 in a research report on Friday, May 15th. Raymond James Financial upgraded Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price target on the stock in a report on Friday, March 20th. Truist Financial raised their price target on Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a research report on Wednesday, May 20th. Royal Bank Of Canada raised shares of Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price objective for the company in a research note on Wednesday, June 3rd. Finally, Weiss Ratings cut shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, April 6th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $10.50.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Dynamic Technology Lab Private Ltd grew its stake in shares of Aveanna Healthcare by 8.9% during the third quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock valued at $126,000 after buying an additional 1,151 shares during the last quarter. Barclays PLC lifted its stake in shares of Aveanna Healthcare by 0.8% during the 3rd quarter. Barclays PLC now owns 179,359 shares of the company’s stock worth $1,591,000 after acquiring an additional 1,366 shares during the last quarter. Franklin Resources Inc. lifted its stake in shares of Aveanna Healthcare by 4.5% during the 3rd quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock worth $316,000 after acquiring an additional 1,528 shares during the last quarter. Intech Investment Management LLC boosted its holdings in Aveanna Healthcare by 9.8% during the 4th quarter. Intech Investment Management LLC now owns 19,483 shares of the company’s stock valued at $159,000 after acquiring an additional 1,739 shares during the period. Finally, Balboa Wealth Partners boosted its holdings in Aveanna Healthcare by 13.5% during the 4th quarter. Balboa Wealth Partners now owns 16,890 shares of the company’s stock valued at $138,000 after acquiring an additional 2,007 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.